Erasca, Inc. Employee Count
The employee counts Erasca, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 103; Filing 2026-03-12; Lease expense per employee $83,300.97.
- 2024-12-31: Employees (as filed) 103; Filing 2025-03-20; Lease expense per employee $101,320.39.
- 2023-12-31: Employees (as filed) 126; Filing 2024-03-27; Lease expense per employee $90,277.78.
- 2022-12-31: Employees (as filed) 129; Filing 2023-03-23; Lease expense per employee $59,689.92.
- Available history
- 2021-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 103 full-time | 2026-03-12 | $83,300.97 total lease cost |
| 2024-12-31 | 103 full-time | 2025-03-20 | $101,320.39 total lease cost |
| 2023-12-31 | 126 full-time | 2024-03-27 | $90,277.78 total lease cost |
| 2022-12-31 | 129 full-time | 2023-03-23 | $59,689.92 total lease cost |
| 2021-12-31 | 123 full-time | 2022-03-24 | $22,764.23 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |